Menu

Tirzepatide 5mg is a dual GIP/GLP-1 receptor agonist used for weight loss and type 2 diabetes management.
Instructions for Use:
1. Composition: 5 mg per vial.
2. Dosage: Start at 2.5 mg/week, increase gradually.
3. Administration: Subcutaneous injection.
4. Side Effects: Nausea, delayed gastric emptying.
5. Storage: Refrigerate; protect from light.